Vivek Borse

Vivek Borse

Auto-generated profile, based on publicly available information

Vivek Borse

NanoBioSens Lab, Centre for Nanotechnology, Indian Institute of Technology Guwahati, Guwahati, 781 039, Assam, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Sensors International
Verified
Journal Article
Open access
VBVivek Borse
Vivek Borse
AKAditya Narayan Konwar
Aditya Narayan Konwar
PBPronamika Buragohain
Pronamika Buragohain
Globally, oral cancer is the sixth most common type of cancer with India contributing to almost one-third of the total burden and the second country having the highest number of oral cancer cases. Oral squamous cell carcinoma (OSCC) dominates all the oral cancer cases with potentially malignant disorders, which is also recognized as a detectable pre-clinical phase of oral cancer. Tobacco consumption including smokeless tobacco, betel-quid chewing, excessive alcohol consumption, unhygienic oral condition, and sustained viral infections that include the human papillomavirus are some of the risk aspects for the incidence of oral cancer. Lack of knowledge, variations in exposure to the environment, and behavioral risk factors indicate a wide variation in the global incidence and increases the mortality rate. This review describes various risk factors related to the occurrence of oral cancer, the statistics of the distribution of oral cancer in India by various virtues, and the socio-economic positions. The various conventional diagnostic techniques used routinely for detection of the oral cancer are discussed along with advanced techniques. This review also focusses on the novel techniques developed by Indian researchers that have huge potential for application in oral cancer diagnosis.

1 October 2019 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
SBSOUNAK BAGCHI
SOUNAK BAGCHI
TCTanya Chhibber
Tanya Chhibber
BLBehnaz Lahooti
Behnaz Lahooti
AVAngela Verma
Angela Verma
VBVivek Borse
Vivek Borse
Rahul Dev JayantRahul Dev Jayant
Rahul Dev Jayant
The blood-brain barrier (BBB) is comprised of brain microvascular endothelial central nervous system (CNS) cells, which communicate with other CNS cells (astrocytes, pericytes) and behave according to the state of the CNS, by responding against pathological environments and modulating disease progression. The BBB plays a crucial role in maintaining homeostasis in the CNS by maintaining restricted transport of toxic or harmful molecules, transport of nutrients, and removal of metabolites from the brain. Neurological disorders, such as NeuroHIV, cerebral stroke, brain tumors, and other neurodegenerative diseases increase the permeability of the BBB. While on the other hand, semipermeable nature of BBB restricts the movement of bigger molecules i.e. drugs or proteins (>500 kDa) across it, leading to minimal bioavailability of drugs in the CNS. This poses the most significant shortcoming in the development of therapeutics for CNS neurodegenerative disorders. Although the complexity of the BBB (dynamic and adaptable barrier) affects approaches of CNS drug delivery and promotes disease progression, understanding the composition and functions of BBB provides a platform for novel innovative approaches towards drug delivery to CNS. The methodical and scientific interests in the physiology and pathology of the BBB led to the development and the advancement of numerous in vitro models of the BBB. This review discusses the fundamentals of BBB structure, permeation mechanisms, an overview of all the different in-vitro BBB models with their advantages and disadvantages, and rationale of selecting penetration prediction methods towards the critical role in the development of the CNS therapeutics.

1 August 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
PPPravin O. Patil
Pravin O. Patil
GPGaurav R. Pandey
Gaurav R. Pandey
APAshwini G. Patil
Ashwini G. Patil
VBVivek B. Borse
Vivek B. Borse
PDPrashant K. Deshmukh
Prashant K. Deshmukh
SBSanjay B. Bari
Sanjay B. Bari

1 September 2017 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
VBVivek Borse
Vivek Borse
MTMukeshchand Thakur
Mukeshchand Thakur
SSSohini Sengupta
Sohini Sengupta
RSRohit Srivastava
Rohit Srivastava

1 February 2019 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
VBVivek Borse
Vivek Borse
RSRohit Srivastava
Rohit Srivastava

9 June 2020 in Sensors International
Verified
Journal Article
Open access
AKAditya Narayan Konwar
Aditya Narayan Konwar
VBVivek Borse
Vivek Borse
Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings. The conventional clinical diagnostic procedure requires high-end and costly instruments, an expert technician for operation and result interpretation, longer time, etc. that ultimately makes it exhausting and expensive. Although there are a lot of improvements in the medical facilities in the Indian healthcare system, the use of POC diagnostic devices is still in its nascent phase. This review illustrates the status of POC diagnostic devices currently used in clinical setups along with constraints in their use. The devices and technologies that are in the research and development phase across the country that has tremendous potential to elevate the clinical diagnostics scenario along with the diagnosis of ongoing COVID-19 pandemic are emphasized. The implications of using POC diagnostic devices and the future objectives for technological advancements that may eventually uplift the status of healthcare and related sectors in India are also discussed here.